Healthcare • Medical Distribution
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if FOCL is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
6 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bullish
Last trade: buy 58 days ago
Red flags: 0
37 filers reported a long position in FOCL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Soleus Capital Management, L.P. | $37.9M | 7.3M | Unchanged |
| MORGAN STANLEY | $17.3M | 3.3M | -0.3% |
| Rock Springs Capital Management LP | $7.2M | 1.4M | +0.6% |
| FLAX POND CAPITAL, LLC | $3.8M | 736.2K | -6% |
| Bruce & Co., Inc. | $2.3M | 438.7K | Unchanged |
| Parkman Healthcare Partners LLC | $802K | 154.8K | Unchanged |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $756.3K | 146K | New |
| CAHILL FINANCIAL ADVISORS INC | $699.1K | 135K | Unchanged |
| US BANCORP \DE\ | $634.6K | 122.5K | +2.9% |
| UBS Group AG | $613.3K | 118.4K | -30.2% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.